Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Classical hematology 1

Conditions

Carcinoma, Non-Small-Cell Lung 204Neoplasms 119Breast Neoplasms 110Colorectal Neoplasms 97Ovarian Neoplasms 78Prostatic Neoplasms 77Neoplasm Metastasis 76Multiple Myeloma 65Lung Neoplasms 62Squamous Cell Carcinoma of Head and Neck 51Recurrence 49Endometrial Neoplasms 47Pancreatic Neoplasms 46Stomach Neoplasms 42Small Cell Lung Carcinoma 41Leukemia, Lymphocytic, Chronic, B-Cell 41Carcinoma, Renal Cell 41Melanoma 37Lymphoma, Non-Hodgkin 33Leukemia, Myeloid, Acute 33Triple Negative Breast Neoplasms 32Urinary Bladder Neoplasms 29Parkinson Disease 4, Autosomal Dominant Lewy Body 29Lymphoma, Follicular 29Lymphoma, Large B-Cell, Diffuse 28Carcinoma, Hepatocellular 28Head and Neck Neoplasms 26Advanced Solid Tumors 25Esophageal Neoplasms 24Lymphoma 23

Interventions

Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Hemorrhage × 30 days × Clear all
NCT07527832 2026-06-03

An Observational Study to Learn About the Medicine - BEVACIZUMAB BS [Pfizer] in Colorectal Cancer Patients From Japan.

Pfizer

Completed
1,000 enrolled
Gastrointestinal

Hemorrhage, Colorectal Neoplasms

NCT06170619 2026-06-01

OCCLUDE

Boston Scientific Corporation

Completed
125 enrolled

Hemorrhage

NCT07410117 2026-05-27

ROXI-CAT-I

Regeneron Pharmaceuticals

Phase 3 Recruiting
1,120 enrolled
Classical hematology

Hemorrhage, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡